JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Here, we report the case of a patient with <i>JAK2 V617F</i>- positive ET who subsequently acquired BCR-ABL1, which transformed the disease into CML after 10 years from the initial diagnosis.